Alvotech (ALVO)
13.72
-0.28
(-2.00%)
USD |
NASDAQ |
May 23, 10:03
Alvotech Gross Profit Margin (Quarterly): 45.85% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 45.85% |
December 31, 2023 | -5.67% |
September 30, 2023 | -105.3% |
June 30, 2023 | -556.2% |
March 31, 2023 | -146.4% |
Date | Value |
---|---|
December 31, 2022 | -20.43% |
September 30, 2022 | 7.89% |
June 30, 2022 | 59.50% |
March 31, 2022 | -286.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-556.2%
Minimum
Jun 2023
59.50%
Maximum
Jun 2022
-112.0%
Average
-20.43%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
AbbVie Inc | 66.74% |
Teva Pharmaceutical Industries Ltd | 46.37% |
Moolec Science SA | 92.05% |
Procaps Group SA | 57.77% |
NeuroMetrix Inc | 47.28% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -51.75% |
Return on Invested Capital | -231.8% |
Profit Margin (Quarterly) | -593.5% |
Operating Margin (Quarterly) | -131.4% |
Return on Net Operating Assets | -96.53% |